-
Deferasirox, sold
under the
brand name
Exjade &
Asunra (in
injectable form) &
Oleptiss (Tablet formulation) both by
Novartis among others, is an oral...
-
reverse iron overload,
using drugs such as deferoxamine, deferiprone, or
deferasirox;
medication with the
antioxidant indicaxanthin to
prevent the breakdown...
- chelation, and
folic acid. Iron
chelation may be done with deferoxamine,
deferasirox or deferiprone. Occasionally, a bone
marrow transplant may be an option...
-
methylphenidate (Ritalin;
production ceased 2020),
terbinafine (Lamisil),
deferasirox (Exjade), and others.
Novartis was
formed in 1996 by the
merger of Ciba-Geigy...
-
Chelation therapy Two
molecules of
deferasirox, an
orally administered chelator,
binding iron.
Deferasirox is used in the
treatment of
transfusional iron...
- Po****r
chelators include deferoxamine and deferiprone. The oral
chelator deferasirox was
approved for use in 2005 in some countries. Bone
marrow transplantation...
- Complementary: Desmopressinα
Heparin sodiumα
Protamine sulfateα Warfarinα
Deferasirox Complementary: Deferoxamineα
Hydroxycarbamide (hydroxyurea)α Cryoprecipitate...
- by the FDA and
Novartis was
added to
deferasirox treatment guidelines.
Following postmarketing use of
deferasirox, rare
cases of
acute kidney failure or...
- thal****aemia (and, thus, who
develop iron
overload as a result) are
deferasirox and deferiprone. A
minimally invasive approach to
hereditary hemochromatosis...
-
method has only a
limited efficacy,
unlike small-molecular
chelators (
deferasirox, deferiprone, or deferoxamine), such an
approach may have only minor...
